Literature DB >> 8355116

Variable phenotypes in velocardiofacial syndrome with chromosomal deletion.

B Motzkin1, R Marion, R Goldberg, R Shprintzen, P Saenger.   

Abstract

Velocardiofacial syndrome (VCF) has overlapping features with DiGeorge sequence; both result from a developmental field defect and probably represent contiguous gene deletion syndromes. The association of chromosome 22q11 deletion with DiGeorge sequence led us to do molecular analysis of chromosome 22 in 18 patients with VCF, who ranged in age from 6 to 42 years. All 18 patients had monosomy for the chromosome region 22q11. Retrospectively, we correlated the presence of the deletion with various clinical findings: 100% had cleft palate, 67% the facial phenotype, 83% cardiac disease, 94% learning disabilities, 70% ophthalmologic findings, 50% short stature, 22% psychiatric disorders, and 17% hypocalcemia. Both severely phenotypically affected and mildly affected patients had the deletion. These findings stress the importance of continued surveillance of all patients with VCF for the many medical problems that may not be present at initial diagnosis. We conclude that the presence of the gene deletion does not predict the phenotypic expression in VCF. Further studies to characterize the size of the gene deletion may facilitate better prediction of the phenotype.

Entities:  

Mesh:

Year:  1993        PMID: 8355116     DOI: 10.1016/s0022-3476(05)81740-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

2.  Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.

Authors:  Anne M Moon; Deborah L Guris; Ji-heui Seo; Leiming Li; Jennetta Hammond; Amy Talbot; Akira Imamoto
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

Review 3.  Velocardiofacial syndrome.

Authors:  A C Pike; M Super
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

4.  Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  K E Sullivan; D McDonald-McGinn; D A Driscoll; B S Emanuel; E H Zackai; A F Jawad
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 5.  22q11 deletion syndrome: a genetic subtype of schizophrenia.

Authors:  A S Bassett; E W Chow
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

6.  Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS.

Authors:  A Swillen; K Devriendt; E Legius; B Eyskens; M Dumoulin; M Gewillig; J P Fryns
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

7.  Velocardiofacial syndrome and DiGeorge sequence.

Authors:  R J Shprintzen
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

Review 8.  Phenotype of adults with the 22q11 deletion syndrome: A review.

Authors:  E Cohen; E W Chow; R Weksberg; A S Bassett
Journal:  Am J Med Genet       Date:  1999-10-08

9.  Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report.

Authors:  Karen Zagursky; Ronald A Weller; Naushad Jessani; Jawwad Abbas; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

10.  Ocular findings in children with a microdeletion in chromosome 22q11.2.

Authors:  Ingele Casteels; Patricia Casaer; Marc Gewillig; Ann Swillen; Koenraad Devriendt
Journal:  Eur J Pediatr       Date:  2007-08-18       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.